STOCK TITAN

United Therapeutics (UTHR) director converts 650 RSUs into common stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

UNITED THERAPEUTICS Corp director Nilda Mesa reported the vesting and conversion of equity awards. On July 9, 2026, 650 restricted stock units vested and were converted on a one-for-one basis into 650 shares of common stock. Following this compensation-related transaction, Mesa directly holds 5,678 shares of common stock.

Positive

  • None.

Negative

  • None.
Insider Mesa Nilda
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units 650 $0.00 --
Exercise Common Stock 650 $0.00 --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 5,678 shares (Direct)
Footnotes (1)
  1. Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. Not applicable as restricted stock units do not have an expiration date.
RSUs vested and converted 650 shares Restricted stock units converted one-for-one into common stock on July 9, 2026
Common shares received 650 shares Common Stock acquired via exercise/conversion code M on July 9, 2026
Holdings after transaction 5,678 shares Total United Therapeutics common stock directly held by Nilda Mesa after transaction
Exercise/Conversion price $0.00 per unit Conversion or exercise price for 650 restricted stock units into common stock
Derivative exercise count 1 transaction One derivative exercise/conversion involving restricted stock units
Restricted Stock Units financial
"Shares received upon vesting of restricted stock units on July 9, 2026."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vesting financial
"Shares received upon vesting of restricted stock units on July 9, 2026."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did UNITED THERAPEUTICS (UTHR) director Nilda Mesa report?

Nilda Mesa reported the vesting and conversion of 650 restricted stock units into 650 shares of common stock on July 9, 2026, reflecting a compensation-related equity acquisition rather than an open-market trade.

How many UNITED THERAPEUTICS (UTHR) shares does Nilda Mesa hold after this Form 4?

After the reported transaction, Nilda Mesa directly holds 5,678 shares of UNITED THERAPEUTICS common stock. This total includes the 650 shares received upon vesting and conversion of restricted stock units on July 9, 2026.

Was the UTHR Form 4 transaction a market purchase or sale of shares?

The Form 4 does not report any open-market purchases or sales. It shows an exercise/conversion of derivative security, where 650 restricted stock units vested and converted into 650 common shares at a stated price of $0.00 per unit.

What type of derivative security was involved in the UTHR Form 4 for Nilda Mesa?

The derivative security was restricted stock units that settled in common stock. On July 9, 2026, 650 restricted stock units converted on a one-for-one basis into 650 shares of UNITED THERAPEUTICS common stock upon vesting.

Do the restricted stock units in the UTHR filing have an expiration date?

The filing states that restricted stock units do not have an expiration date. A footnote explains that expiration is "not applicable" for these units, which vested and converted into 650 common shares on July 9, 2026.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mesa Nilda

(Last)(First)(Middle)
C/O UNITED THERAPEUTICS CORPORATION
1000 SPRING STREET

(Street)
SILVER SPRING MARYLAND 20910

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
UNITED THERAPEUTICS Corp [ UTHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/09/2026M(1)650A$0.00(1)5,678D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$0.00(1)07/09/2026M(1)65007/09/2026 (2)Common Stock650$0.00(1)0.00D
Explanation of Responses:
1. Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock.
2. Not applicable as restricted stock units do not have an expiration date.
Remarks:
/s/ John S. Hess, Jr. under Power of Attorney07/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)